Astellas Pharma Inc. ADR logo

Astellas Pharma Inc. ADR (ALPMY)

Market Closed
15 Oct, 08:00 PM
OTC PINK OTC PINK
$
14. 98
+0.63
+4.3902%
$
25.73B Market Cap
- P/E Ratio
0.88% Div Yield
24,104 Volume
- Eps
$ 14.35
Previous Close
Add Transaction
Day Range
14.93 15.03
Year Range
10.05 17.35
Want to track ALPMY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers

Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers

Trump's MFN push expands to nine mid-sized drugmakers, bringing 26 companies under agreements covering 89% of the branded drug market.

Zacks | 1 month ago
New Strong Sell Stocks for August 19th

New Strong Sell Stocks for August 19th

ASEKY, ALPMY and ATS have been added to the Zacks Rank #5 (Strong Sell) List on August 19, 2026.

Zacks | 1 month ago
New Strong Sell Stocks for August 6th

New Strong Sell Stocks for August 6th

COIN, ALPMY and MUX have been added to the Zacks Rank #5 (Strong Sell) List on August 6th, 2026.

Zacks | 2 months ago
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?

Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?

Here is how Astellas Pharma Inc. (ALPMY) and Aurinia Pharmaceuticals (AUPH) have performed compared to their sector so far this year.

Zacks | 3 months ago
Is Astellas Pharma (ALPMY) Stock Undervalued Right Now?

Is Astellas Pharma (ALPMY) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 3 months ago
Is Astellas Pharma (ALPMY) a Great Value Stock Right Now?

Is Astellas Pharma (ALPMY) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 4 months ago
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?

Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?

Here is how Astellas Pharma Inc. (ALPMY) and Aurinia Pharmaceuticals (AUPH) have performed compared to their sector so far this year.

Zacks | 4 months ago
Astellas Pharma Inc. (ALPMY) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Astellas Pharma Inc. (ALPMY) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Astellas Pharma Inc. (ALPMY) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Seekingalpha | 4 months ago
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?

Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?

Here is how Astellas Pharma Inc. (ALPMY) and BillionToOne (BLLN) have performed compared to their sector so far this year.

Zacks | 5 months ago
Astellas Pharma Inc. (ALPMY) Q4 2026 Earnings Call Transcript

Astellas Pharma Inc. (ALPMY) Q4 2026 Earnings Call Transcript

Astellas Pharma Inc. (ALPMY) Q4 2026 Earnings Call Transcript

Seekingalpha | 5 months ago
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?

Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?

Here is how Astellas Pharma Inc. (ALPMY) and Adlai Nortye Ltd. Sponsored ADR (ANL) have performed compared to their sector so far this year.

Zacks | 6 months ago
Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare Transcript

Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare Transcript

Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare Transcript

Seekingalpha | 6 months ago
Loading...
Load More